
    
      The study was terminated on April 26, 2010 due to lack of efficacy, as determined during the
      interim analysis of data in April 2010, showing that the study did not meet its primary
      endpoint to demonstrate a statistically significant improvement in PFS. The decision to
      terminate the trial was not based on any safety concerns.
    
  